STOCK PURCHASE AGREEMENT DATED AS OF AUGUST 30, 2018 BY AND BETWEEN BIOTIME, INC., AGEX THERAPEUTICS, INC. AND JUVENESCENCE LIMITEDStock Purchase Agreement • August 31st, 2018 • Biotime Inc • Biological products, (no disgnostic substances) • New York
Contract Type FiledAugust 31st, 2018 Company Industry JurisdictionTHIS STOCK PURCHASE AGREEMENT (this “Agreement”), dated as of August 30, 2018, is made by and between BioTime, Inc., a California corporation (“Seller”), AgeX Therapeutics, Inc., a Delaware corporation (the “Company”) and Juvenescence Limited, a British Virgin Islands company (“Buyer”).
SHAREHOLDER AGREEMENTShareholder Agreement • August 31st, 2018 • Biotime Inc • Biological products, (no disgnostic substances) • California
Contract Type FiledAugust 31st, 2018 Company Industry Jurisdiction